SCHEMBL17602005

SCHEMBL17602005

C=Cc1cccc2c1N(C)Cc1cc(OCc3ccc(C#N)cc3)c(OCc3ccc(C#N)cc3)cc1-2

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CARM1 Q86X55 1/20 0.40
CHEK1 O14757 2/20 0.35
MAOB P27338 4/20 0.34
MAOA P21397 2/20 0.34
MAPT P10636 1/20 0.34
TSHR P16473 1/20 0.34
RECQL P46063 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
POLB P06746 1/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
MAPK1 P28482 1/20 0.33
HSD17B10 Q99714 1/20 0.33
CCR5 P51681 1/20 0.33
CYP11B1 P15538 1/20 0.33
MET P08581 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17601979 0.88 CHRNA7 (0.43) CARM1MAPTMAPK1
SCHEMBL22761235 0.82 ACHE (0.38)
SCHEMBL22761232 0.81 ACHE (0.38) MAPTALDH1A1
SCHEMBL17601999 0.80 ADRA2A (0.41) TSHRHPGDMAPK1HSD17B10
SCHEMBL16002508 0.79 HTR1A (0.36) MAOBMAOA
SCHEMBL22761237 0.78 ACHE (0.36)
SCHEMBL22271831 0.77 ACHE (0.52) MAOBMAOAMAPTHPGDMAPK1
SCHEMBL17602004 0.77 MAOA (0.35) MAOBMAOAHPGD
SCHEMBL17601996 0.77 ABCB1 (0.40) ALDH1A1
SCHEMBL22760876 0.76 ACHE (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9682954-B2 Phenanthridine derivatives, preparation methods and uses thereof KUNMING INSTITUTE OF BOTANY, THE CHINESE ACADEMY OF SCIENCES (CN) 2017-06-20 US claimed
US-20160083364-A1 Phenanthridine Derivatives, Preparation Methods and Uses Thereof CENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE ACADEMY OF SCIENCES (CN) 2016-03-24 US claimed
US-9682954-B2 Phenanthridine derivatives, preparation methods and uses thereof KUNMING INSTITUTE OF BOTANY, THE CHINESE ACADEMY OF SCIENCES (CN) 2017-06-20 US disclosed
US-20160083364-A1 Phenanthridine Derivatives, Preparation Methods and Uses Thereof CENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE ACADEMY OF SCIENCES (CN) 2016-03-24 US disclosed
CN-103145617-A Phenanthridine derivative as well as medicinal composition, preparation method and application thereof KUNMING INST BOTANY CN ACAD 2013-06-12 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160083364-A1 Phenanthridine Derivatives, Preparation Methods and Uses Thereof CTNNB1, WNT3A, WNT1 CARM1 4319/4885CHEK1 4580/4885MAOB 474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.